Full Press Release Details
Prestige Consumer Healthcare Inc Completes Acquisition of Breathe
TARRYTOWN, N.Y., June 15, 2026 (GLOBE NEWSWIRE) -- Prestige Consumer
Healthcare Inc. (NYSE:PBH) ("Prestige") today announced that it has closed the previously announced acquisition of the Breathe
Right brand and certain other brands.
The closing was finalized pursuant to the terms of the asset purchase
agreement, announced on March 20, 2026, under which Prestige agreed to acquire the Breathe Right brand and certain other
brands from Foundation Consumer Healthcare for $1.045 billion, or approximately $900 million net of anticipated tax benefits valued at
$150 million. Breathe Right , created in the 1990s, is an iconic #1 brand synonymous with the nasal strip category. It
will become the company's largest brand and represents expansion into a new category for Prestige.
The Company financed the transaction with a combination of available
cash on hand and a completed financing of a new Term Loan B.
Further details regarding the transaction and benefits of Prestige
are detailed in a presentation dated March 20, 2026 available on the Company's website at https://ir.prestigebrands.com/.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets,
sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia,
and in certain other international markets. The Company's diverse portfolio of brands include Breathe Right nasal strips,
Monistat and Summer's Eve women's health products, BC and Goody's pain
relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products,
Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and
Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric
over-the-counter products, Boudreaux's Butt Paste diaper rash ointments, Nix lice treatment,
Debrox earwax remover, Gaviscon antacid in Canada, and Hydralyte rehydration
products and the Fess line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact
Phil Terpolilli, CFA, 914-524-6819